Welcome To ChemAnalyst
As Q* moves forward in December, throughout the month suppliers and distributors across the domestic market rated limited price corrections, with most transactions concluding at progressively higher levels following the market dynamics of the past month. The price firmness with values rising by *.*** largely mirrored the previous month’s Cetirizine Dihydrochloride pricing pattern, when import costs had already begun climbing due to reduced availability from key exporting regions. As December unfolded, those pressures not only persisted but intensified, leaving buyers with limited negotiating leverage and encouraging suppliers to maintain firm Cetirizine Dihydrochloride offers.
One of the major contributing factors for the consistent increase in the price of Cetirizine Dihydrochloride was the limited supply in the key manufacturing areas of the Asian regions, where the product faced higher energy expenses, higher labor costs, and tough environmental regulation standards. All these added up to higher export prices, which in...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.

Leave a Comment
Comments (0)